Evidence map›Paper›PMID 36873897›Full record

ArticleFrontiers in medicine2023

Fine-tuning characterization of patients with interstitial pneumonia and an underlying autoimmune disease in real-world practice: We get closer with Nailfold videocapillaroscopy.

Fredeswinda Isabel Romero-Bueno, Maria Jesús Rodríguez-Nieto, Carmelo Palacios Miras, Lina Martínez Estupiñán, Maria José Martínez-Becerra, Maria Carmen Vegas Sánchez, Oderay Mabel Cedeño Díaz, Olga Sánchez-Pernaute, NEREA Autoimmune ILD Study Group

Open access · goldAbstract read
In one paragraph

Article in Frontiers in medicine, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
1.3field-weighted citation impact, top 19% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 5 citations in OpenAlex.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 1 institution in 1 country.

Fredeswinda Isabel Romero-BuenoRheumatology Department, IIS-HU Fundación Jiménez Díaz, Autonoma University, Madrid, Spain.
Maria Jesús Rodríguez-NietoDepartment of Pulmonology, IIS-HU Fundación Jiménez Díaz, Autonoma University and CIBERES, Madrid, Spain.
Carmelo Palacios MirasDepartment of Imaging, IIS-HU Fundación Jiménez Díaz, Autonoma University, Madrid, Spain.
Lina Martínez EstupiñánRheumatology Department, IIS-HU Fundación Jiménez Díaz, Autonoma University, Madrid, Spain.
Maria José Martínez-BecerraDepartment of Immunology, IIS-HU Fundación Jiménez Díaz, Autonoma University, Madrid, Spain.
Maria Carmen Vegas SánchezDepartment of Immunology, IIS-HU Fundación Jiménez Díaz, Autonoma University, Madrid, Spain.
Oderay Mabel Cedeño DíazDepartment of Pathology, IIS-HU Fundación Jiménez Díaz, Autonoma University, Madrid, Spain.
Olga Sánchez-PernauteRheumatology Department, IIS-HU Fundación Jiménez Díaz, Autonoma University, Madrid, Spain.
NEREA Autoimmune ILD Study Group
Hospital Universitario Fundación Jiménez Díaz · ES

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Objectives: To assess performance of interstitial pneumonia (IP) with autoimmune features (IPAF) criteria in clinical practice and describe the utility of additional workup in identifying patients with underlying connective tissue diseases (CTD). Methods: We set a retrospective study of our patients with autoimmune IP, who were allocated to CTD-IP, IPAF or undifferentiated autoimmune IP (uAIP) subgroups according to the updated classification criteria. Presence of the process-related variables comprising IPAF defining domains was scrutinized in all patients, and, when available, the results of nailfold videocapillaroscopy (NVC) were recorded. Results: Thirty nine out of 118 patients, accounting for 71% of former undifferentiated cases, fulfilled IPAF criteria. Arthritis and Raynaud's phenomenon were prevalent in this subgroup. While systemic sclerosis-specific autoantibodies were restricted to CTD-IP patients, anti-tRNA synthetase antibodies were also present in IPAF. In contrast, rheumatoid factor, anti-Ro antibodies and ANA nucleolar patterns could be found in all subgroups. Usual interstitial pneumonia (UIP) / possible UIP were the most frequently observed radiographic patterns Therefore, the presence of thoracic multicompartimental findings as also performance of open lung biopsies were useful in characterizing as IPAF those UIP cases lacking a clinical domain. Interestingly, we could observe NVC abnormalities in 54% of IPAF and 36% of uAIP tested patients, even though many of them did not report Raynaud's phenomenon. Conclusion: Besides application of IPAF criteria, distribution of IPAF defining variables along with NVC exams help identify more homogeneous phenotypic subgroups of autoimmune IP of potential relevance beyond clinical diagnosis.

Indexed as

anti synthetase syndromeconnective tissue diseases (CTD)interstitial pneumonia (iP)interstitial pneumonia with autoimmune features (IPAF)nailfold videocapillaroscopy

Identifiers

PMID36873897
PMCPMC9975591
OpenAlexW4320918126

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.